Robert W. Schnepp

3.1k total citations
37 papers, 2.0k citations indexed

About

Robert W. Schnepp is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Robert W. Schnepp has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Robert W. Schnepp's work include Neuroblastoma Research and Treatments (16 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Robert W. Schnepp is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Robert W. Schnepp collaborates with scholars based in United States, South Korea and Spain. Robert W. Schnepp's co-authors include Xianxin Hua, Ping La, Sharon J. Diskin, John M. Maris, Edward F. Attiyeh, Hua Mao, Kristina A. Cole, Erica L. Carpenter, Stephen M. Sykes and Haoren Wang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert W. Schnepp

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Schnepp United States 18 1.0k 686 655 598 288 37 2.0k
Keiko Funa Sweden 20 716 0.7× 609 0.9× 255 0.4× 356 0.6× 215 0.7× 37 1.6k
Edward F. Attiyeh United States 24 1.5k 1.5× 776 1.1× 1.4k 2.1× 217 0.4× 1.0k 3.6× 47 2.7k
Nicolas Sévenet France 20 2.3k 2.3× 575 0.8× 311 0.5× 274 0.5× 329 1.1× 51 3.1k
Stefano Barbi Italy 19 547 0.5× 932 1.4× 366 0.6× 711 1.2× 208 0.7× 33 1.6k
R P Castleberry United States 23 1.2k 1.2× 382 0.6× 2.1k 3.1× 412 0.7× 715 2.5× 36 2.7k
Rossano Cesari United States 20 1.1k 1.1× 664 1.0× 142 0.2× 179 0.3× 268 0.9× 34 2.1k
Nadem Soufir France 22 877 0.9× 649 0.9× 86 0.1× 243 0.4× 323 1.1× 47 1.7k
J. Schütte Germany 27 1.1k 1.1× 889 1.3× 216 0.3× 187 0.3× 274 1.0× 76 2.7k
Elvis Terci Valera Brazil 18 725 0.7× 275 0.4× 227 0.3× 151 0.3× 186 0.6× 108 1.4k
Siradanahalli C. Guru United States 17 539 0.5× 963 1.4× 840 1.3× 1.3k 2.1× 82 0.3× 22 1.9k

Countries citing papers authored by Robert W. Schnepp

Since Specialization
Citations

This map shows the geographic impact of Robert W. Schnepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Schnepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Schnepp more than expected).

Fields of papers citing papers by Robert W. Schnepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Schnepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Schnepp. The network helps show where Robert W. Schnepp may publish in the future.

Co-authorship network of co-authors of Robert W. Schnepp

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Schnepp. A scholar is included among the top collaborators of Robert W. Schnepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Schnepp. Robert W. Schnepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leighl, Natasha B., José Trigo, Keunchil Park, et al.. (2025). Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer. Lung Cancer. 205. 108579–108579. 1 indexed citations
2.
Raghav, Kanwal, Eric Van Cutsem, Dirk Arnold, et al.. (2025). Amivantamab with or without chemotherapy in right-sided metastatic colorectal cancer: Updated results from OrigAMI-1, an open-label, phase 1b/2 study.. Journal of Clinical Oncology. 43(4_suppl). 197–197. 1 indexed citations
3.
Ho, Gwo Fuang, Yanggang Yuan, Xin Liang, et al.. (2024). 513MO Amivantamab plus FOLFOX or FOLFIRI in metastatic colorectal cancer: Results from OrigAMI-1, an open-label, phase Ib/II study. Annals of Oncology. 35. S434–S434. 2 indexed citations
4.
Juraschka, Kyle, Sachin Kumar, Olivier Saulnier, et al.. (2023). The LIN28B –let‐7– PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. Molecular Oncology. 17(9). 1784–1802. 5 indexed citations
5.
Sadanand, Arhanti, Victor Maximov, Suttipong Suttapitugsakul, et al.. (2023). Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Reports Medicine. 4(6). 101091–101091. 12 indexed citations
6.
7.
Leighl, N. B., Catherine A. Shu, Anna Minchom, et al.. (2021). 1192MO Amivantamab monotherapy and in combination with lazertinib in post-osimertinib EGFR-mutant NSCLC: Analysis from the CHRYSALIS study. Annals of Oncology. 32. S951–S952. 20 indexed citations
8.
Martínez, Daniel, Jennifer Pogoriler, Komal S. Rathi, et al.. (2021). Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Molecular Oncology. 15(8). 2156–2171. 8 indexed citations
9.
Schnepp, Robert W., et al.. (2020). YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma. Cancer Research. 80(21). 4741–4753. 14 indexed citations
10.
Cox, Julie, Melanie Weingart, Komal S. Rathi, et al.. (2020). LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase. Neoplasia. 22(6). 231–241. 19 indexed citations
11.
Schnepp, Robert W., Edward F. Attiyeh, Pichai Raman, et al.. (2015). A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell. 28(5). 599–609. 83 indexed citations
12.
Rader, JulieAnn, Mike R. Russell, Lori S. Hart, et al.. (2013). Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma. Clinical Cancer Research. 19(22). 6173–6182. 308 indexed citations
13.
Diskin, Sharon J., Mario Capasso, Robert W. Schnepp, et al.. (2012). Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nature Genetics. 44(10). 1126–1130. 199 indexed citations
14.
La, Ping, Yuqing Yang, Satyajit Karnik, et al.. (2007). Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1. Journal of Biological Chemistry. 282(43). 31332–31340. 31 indexed citations
15.
La, Ping, et al.. (2006). Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene. 25(25). 3537–3546. 83 indexed citations
16.
Schnepp, Robert W.. (2006). Cyanide: Sources, Perceptions, and Risks. Journal of Emergency Nursing. 32(4). S3–S7. 28 indexed citations
17.
Milne, Thomas A., Christina M. Hughes, Ricardo V. Lloyd, et al.. (2005). Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proceedings of the National Academy of Sciences. 102(3). 749–754. 352 indexed citations
18.
La, Ping, Zhaoyuan Hou, Haoren Wang, et al.. (2004). Direct Binding of DNA by Tumor Suppressor Menin. Journal of Biological Chemistry. 279(47). 49045–49054. 62 indexed citations
19.
Schnepp, Robert W., Hua Mao, Stephen M. Sykes, et al.. (2004). Menin Induces Apoptosis in Murine Embryonic Fibroblasts. Journal of Biological Chemistry. 279(11). 10685–10691. 71 indexed citations
20.
Chen, Fabian, Hyun Kook, Rita Milewski, et al.. (2002). Hop Is an Unusual Homeobox Gene that Modulates Cardiac Development. Cell. 110(6). 713–723. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiko Funa Breakdown of academic impact, for papers by Edward F. Attiyeh Breakdown of academic impact, for papers by Nicolas Sévenet Breakdown of academic impact, for papers by Stefano Barbi Breakdown of academic impact, for papers by R P Castleberry Breakdown of academic impact, for papers by Rossano Cesari Breakdown of academic impact, for papers by Nadem Soufir Breakdown of academic impact, for papers by J. Schütte Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by Siradanahalli C. Guru
Rankless by CCL
2026